Gallium Ga 68 Gozetotide
Small Molecule
Overview
Gallium Ga 68 Gozetotide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL5095039).
Patent & exclusivity (US)
Per the FDA Orange Book (7 approved US products), the latest listed US patent on Gallium Ga 68 Gozetotide expires 9 Mar 2036. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- oxidanium;2-[[5-[3-[[6-[[(5S)-5-carboxy-5-[[(1S)-1,3-dicarboxypropyl]carbamoylamino]pentyl]amino]-6-oxohexyl]amino]-3-oxopropyl]-2-oxidophenyl]methyl-[2-[[5-(2-carboxyethyl)-2-oxidophenyl]methyl-(carboxylatomethyl)amino]ethyl]amino]acetate;gallium-68(3+)
- Canonical SMILES
- C1=CC(=C(C=C1CCC(=O)NCCCCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O)CN(CCN(CC2=C(C=CC(=C2)CCC(=O)O)[O-])CC(=O)[O-])CC(=O)[O-])[O-].[OH3+].[68Ga+3]
- InChIKey
- ZSLQZWHCPBAGKD-RDIOTIBJSA-K
Verified Supplier Partner
Do you supply Gallium Ga 68 Gozetotide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.